IC

Ikarian Capital Portfolio holdings

AUM $302M
1-Year Return 65.21%
This Quarter Return
+12.24%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$109M
AUM Growth
–
Cap. Flow
+$109M
Cap. Flow %
100%
Top 10 Hldgs %
54.39%
Holding
91
New
53
Increased
–
Reduced
–
Closed
–

Top Buys

1
AUPH icon
Aurinia Pharmaceuticals
AUPH
$9.75M
2
SAGE
Sage Therapeutics
SAGE
$9.6M
3
IMVT icon
Immunovant
IMVT
$8M
4
APTO
Aptose Biosciences, Inc.
APTO
$5.73M
5
CHMA
Chiasma, Inc. Common Stock
CHMA
$5.47M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 91.81%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BHVN
51
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$35K 0.01%
+642
New +$35K
ALPN
52
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$18K ﹤0.01%
+4,739
New +$18K
APLS icon
53
Apellis Pharmaceuticals
APLS
$3.55B
$2K ﹤0.01%
+53
New +$2K
ACAD icon
54
Acadia Pharmaceuticals
ACAD
$4.25B
– –
0
– –
ADVM icon
55
Adverum Biotechnologies
ADVM
$67.4M
– –
0
– –
AGIO icon
56
Agios Pharmaceuticals
AGIO
$2.1B
– –
0
– –
ALLK
57
DELISTED
Allakos
ALLK
– –
0
– –
AMRN
58
Amarin Corp
AMRN
$311M
– –
0
– –
ARVN icon
59
Arvinas
ARVN
$563M
– –
0
– –
ARWR icon
60
Arrowhead Research
ARWR
$3.91B
– –
0
– –
ASND icon
61
Ascendis Pharma
ASND
$12.2B
– –
0
– –
AXSM icon
62
Axsome Therapeutics
AXSM
$6.12B
– –
0
– –
CHRS icon
63
Coherus Oncology, Inc. Common Stock
CHRS
$153M
– –
0
– –
CRSP icon
64
CRISPR Therapeutics
CRSP
$4.77B
– –
0
– –
CVM icon
65
CEL-SCI Corp
CVM
$73.5M
– –
0
– –
GILD icon
66
Gilead Sciences
GILD
$142B
– –
0
– –
GOSS icon
67
Gossamer Bio
GOSS
$596M
– –
0
– –
IBB icon
68
iShares Biotechnology ETF
IBB
$5.73B
– –
0
– –
INCY icon
69
Incyte
INCY
$16.7B
– –
0
– –
INSM icon
70
Insmed
INSM
$29.8B
– –
0
– –
KPTI icon
71
Karyopharm Therapeutics
KPTI
$57.3M
– –
0
– –
NBIX icon
72
Neurocrine Biosciences
NBIX
$14.3B
– –
0
– –
SLDB icon
73
Solid Biosciences
SLDB
$427M
– –
0
– –
SRPT icon
74
Sarepta Therapeutics
SRPT
$1.92B
– –
0
– –
WVE icon
75
Wave Life Sciences
WVE
$1.3B
– –
0
– –
1 2
3
4